Found 30 matching trials
Efficacy of Low-Intensity Shockwave Therapy in Treating Radiation Cystitis
EARLY_PHASE1Radiation-induced cystitis is a condition commonly seen in patients who hav...
Location
Ramathibodi Hospital
Using Behavioral Therapy in Combination With Darifenacin for Symptoms of Overactive Bladder
PHASE4This study is designed to investigate the efficacy and safety of treatment ...
Location
Alabama Research Center
A Study to Assess the Safety, Tolerability, and Pharmacology of Darifenacin in Patients With ALS
PHASE2Amyotrophic lateral sclerosis (ALS) is a progressive neurological disorder ...
Location
Ottawa Hospital Research Institute
FREEDOM - First Real-Life Evaluation of Enablex Done in ZA Overactive Bladder Patients During a 3 Months Period
N/APatient perspective on Overactive Bladder and symptoms experienced after ad...
Location
Multiple Locations
Cognitive Effects of Darifenacin and Oxybutynin Extended Release in Volunteers Aged 60 and Over
PHASE2The purpose of this study is to explore the possible cognitive effects of d...
Location
Washington Neuropsychological Institute LLC Georgetown
Behavioural Therapy With Checklist for Overactive Bladder
NAThe aim of this study is to investigate the efficiency of this newly-establ...
Location
Ankara Training and Research Hospital
Pharmacologic Effects of Darifenacin and Tolterodine on Cardiovascular Parameters in Healthy Subjects
PHASE4This study will evaluate the pharmacologic effects of exposure to darifenac...
Location
Investigative Site
A Prospective, Observational, Multicenter Study of Patients Following Initiation of a New Course of Treatment for Overactive Bladder (OAB)
N/AA study to identify factors that are associated with improved effectiveness...
InSite for Over Active Bladder
PHASE4The purposes of this study are:
1. To provide evidence from a randomized c...
Location
Multiple Locations
Comparative Study of the Efficacy and Safety of Muscarinic M3 Receptors Antagonists in the Treatment of Neurogenic Detrusor Overactivity
PHASE4This is a phase IV, double-blind, multicenter, randomized trial evaluating ...
Location
University of Manitoba, Health Sciences Centre